Status:
COMPLETED
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
Lead Sponsor:
Stanford University
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Eligibility Criteria
Inclusion
- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors
Exclusion
- Patients without non-small cell lung cancer
Key Trial Info
Start Date :
September 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00185913
Start Date
September 1 2000
End Date
May 1 2008
Last Update
April 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305